BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25188231)

  • 1. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.
    Arrabal-Polo MA; Cano-García Mdel C; Canales BK; Arrabal-Martín M
    Curr Opin Urol; 2014 Nov; 24(6):633-8. PubMed ID: 25188231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis.
    Arrabal-Polo MÁ; Sierra Girón-Prieto M; Orgaz-Molina J; Zuluaga-Gómez A; Arias-Santiago S; Arrabal-Martín M
    Actas Urol Esp; 2013 Jun; 37(6):362-7. PubMed ID: 23411066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
    Arrabal-Polo MA; Arias-Santiago S; de Haro-Muñoz T; Lopez-Ruiz A; Orgaz-Molina J; Gonzalez-Torres S; Zuluaga-Gomez A; Arrabal-Martin M
    Urology; 2013 Apr; 81(4):731-7. PubMed ID: 23375914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral density and bone remodelling markers in patients with calcium lithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; de Haro-Munoz T; Lopez-Leon VM; Merino-Salas S; Ochoa-Hortal MA; Garrido-Gomez J; Lahoz-Garcia C; Zuluaga-Gomez A
    BJU Int; 2011 Dec; 108(11):1903-8; discussion 1908. PubMed ID: 21554525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; de Haro-Muñoz T; Poyatos-Andujar A; Palæo-Yago F; Zuluaga-Gomez A
    Urology; 2012 Jan; 79(1):48-54. PubMed ID: 21908029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is kidney stone a bone disease?].
    Stoermann Chopard C; Jaeger P
    Rev Med Suisse; 2009 Jun; 5(207):1314-7. PubMed ID: 19626931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
    Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A
    BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.
    Letavernier E; Traxer O; Daudon M; Tligui M; Hubert-Brierre J; Guerrot D; Sebag A; Baud L; Haymann JP
    Clin J Am Soc Nephrol; 2011 May; 6(5):1149-54. PubMed ID: 21441130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
    Girón-Prieto MS; Arias-Santiago S; Del Carmen Cano-García M; Poyatos-Andújar A; de Haro-Muñoz T; Abad-Menor F; Quesada-Charneco M; Arrabal-Polo MÁ; Arrabal-Martín M
    Int Urol Nephrol; 2016 Nov; 48(11):1777-1781. PubMed ID: 27376897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
    Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
    Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density.
    Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; De Haro-Muñoz TD; Zuluaga-Gomez A
    Singapore Med J; 2012 Dec; 53(12):808-13. PubMed ID: 23268154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopenia/osteoporosis in patients with calcium nephrolithiasis.
    Arrabal-Polo MA; Arrabal-Martin M; Girón-Prieto MS; Poyatos-Andujar A; Garrido-Gomez J; Zuluaga-Gomez A; Arias-Santiago S
    Urol Res; 2012 Dec; 40(6):709-16. PubMed ID: 22886308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between bone and stone formation.
    Krieger NS; Bushinsky DA
    Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic hypercalciuria. Diagnosis and treatment].
    Olefir YV; Yavorskii AN; Butnaru DV; Shatalova OV; Gorbatenko VS; Gerasimenko AS
    Urologiia; 2017 Dec; (6):112-119. PubMed ID: 29376607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.